Browsed by
Category: Senate HELP Committee

Science policy weekly roundup: August 31, 2018 ?>

Science policy weekly roundup: August 31, 2018

Senate committee holds hearing on nomination of Kelvin Droegemeier to head OSTP Science Policy Analyst André Porter discusses last week’s U.S. Senate committee hearing to nominate Kelvin Droegemeier to lead the Office of Science and Technology Policy. Several senators asked the nominee about how he would ensure that scientific evidence would be taken seriously by the administration. Droegemeier, a meteorologist, also side-stepped questions regarding whether humans were responsible for climate change. Read more here.   Elizabeth Warren raises concern about…

Read More Read More

Sen. Warren, D-Mass., raises concern about private funding to the NIH ?>

Sen. Warren, D-Mass., raises concern about private funding to the NIH

When National Institutes of Health Director Francis S. Collins testified before a U.S. Senate committee last week about prioritizing cures, most senators asked him about how research is progressing on specific diseases. U.S. Sen. Elizabeth Warren, a Democrat from Massachusetts, however, raised questions about the role of the Foundation for the NIH in soliciting private dollars to fund NIH studies. Established by Congress in 1990, the FNIH is a nonprofit that solicits donations from companies and other organizations to help…

Read More Read More

Science policy weekly roundup: August 24, 2018 ?>

Science policy weekly roundup: August 24, 2018

  What do you think about NIH efforts to support next generation of researchers? The National Institutes of Health is proposing recommendations to support the next generation of researchers, and we at the American Society for Biochemistry and Molecular Biology want to know what you think. We will collect your feedback and send it to the NIH. Submit your opinion and view a timeline of the ASBMB’s involvement here. U.S. Senate passes NIH appropriations bill In an 85-7 vote on…

Read More Read More

21st Century Cures Heads to the Senate ?>

21st Century Cures Heads to the Senate

With bipartisan support, the 21st Century Cures Act was passed on the floor of the House of Representatives by a vote of 344-77 after overcoming a variety of political challenges.  This bill provides $1.86 billion per year in mandatory funding for the National Institutes of Health from fiscal 2016 to FY20 through an innovation fund and seeks to streamline the approval process for drugs from the Food and Drug Administration.